Cancers

What You May Not Know About Breast Cancer

Breast cancer is the most commonly diagnosed cancer in women worldwide. Skin cancer is the most common cancer diagnosed in the United States. What do these two cancers have in common, you might wonder? On a cellular and genetic level, several cancers share more in common than you might think. But with the case of breast cancer and melanoma, there have been several studies that show a link between the two.

One of the most common concerns of a breast cancer survivor following successful treatment is recurrence. Breast cancer survivors can be subject to a myriad of different medical concerns following their diagnosis, but the threat of additional cancer remains a looming one for many. A second breast cancer is the most common second cancer for survivors. This includes cancer in the same breast for those who opted for a breast-conserving lumpectomy, as well as the development of cancer in the breast opposite the one originally diagnosed. However, breast cancer survivors are also at an increased risk for several other cancers, including melanoma, colon cancer, sarcomas, thyroid cancer, and others.

Some of these cancers can be linked to radiation treatment, including lung cancer. Several studies have shown a longitudinal link between radiation therapy for breast cancer and an increased predisposition to lung cancer. However, it is important to note that, for many, radiation therapy helped to increase life expectancy as well. Understanding the potential costs and benefits of different treatment options can be complex. It is important, as always, to speak with your doctor(s) about the available options in order to understand the dynamics involved. Weighing the options is an important decision, and it should be an informed one.

Dr. James Goydos

James Goydos, M.D., F.A.C.S – Physician and surgeon specializing in Surgical Oncology. Experienced Professor of Surgery with a demonstrated history of working in the hospital & healthcare industry. Research has translated into clinical trials for patients with melanoma. Recognized for leadership in patient care by the Melanoma Research Foundation and The Cancer Institute of New Jersey (CINJ). Currently serve on the editorial board of the journal Clinical Cancer Research. Doctor of Medicine from Rutgers, Robert Wood Johnson Medical School.

Recent Posts

10 Things Health Leaders Need to Consider About AI Now

Artificial intelligence moves quickly. Wisdom often takes longer to catch up. That may be why…

7 hours ago

Four Days Before Dolly Parton Died, She Was Talking About the Future

Four days before Dolly Parton died, she was still planning. She was 80. She had…

7 hours ago

Nutrition Advice Keeps Changing — And What Never Changes

For decades we’ve been told to avoid eggs, butter, whole milk, and red meat. Then…

7 hours ago

Loneliness Is Not Just a Feeling. It’s a Biological Emergency

Most of us were taught that loneliness is a mood. You feel sad, you miss…

1 week ago

The Hidden “Friction Tax”

Health innovation loves the language of efficiency: faster, smarter, automated, digital, self-service and AI-enabled. Those…

2 weeks ago

The Same Farm. Two Days. Two Different Worlds

My artistic wife recently painted a working farm near our vacation home on Maryland’s Eastern…

2 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More